Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daniel Baum Company is a private, family-owned U.S. animal health and nutrition company focused on science-based, largely natural products for livestock, poultry, equine, canine, and deer markets. Founded in 1984 and headquartered in Lancaster, Pennsylvania, the company developed out of the Baum family’s food manufacturing business and positions itself as a biotechnology-based provider of animal wellness, productivity, and performance solutions. Its portfolio is commercial rather than drug-development oriented, spanning DBC Ag Products and acquired brands including LIRA GOLD, KAUFFMAN’S Premium Equine Supplements, and Fortitude Canine. The company markets feed supplements, eubiotic and digestive-support products, immune-support products, electrolyte and wellness formulations, and forage-related products through agricultural and veterinary distribution channels. Daniel Baum Company appears to be an operating commercial animal-health business rather than a human biopharma developer with a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daniel Baum Company.